miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancerHao‐Yi Li, Pei‐Jung Lu|Breast Cancer Research|2017Cited by 170
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinomaCheng‐Han Lin, Pei‐Jung Lu|Oncotarget|2016Cited by 34